These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2848122)

  • 1. Cyclic AMP turnover in response to prostaglandins in intact platelets: evidence for separate stimulatory and inhibitory prostaglandin receptors.
    Ashby B
    Second Messengers Phosphoproteins; 1988; 12(1):45-57. PubMed ID: 2848122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model of prostaglandin-regulated cyclic AMP metabolism in intact platelets: examination of time-dependent effects on adenylate cyclase and phosphodiesterase activities.
    Ashby B
    Mol Pharmacol; 1989 Dec; 36(6):866-73. PubMed ID: 2481225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic evidence indicating separate stimulatory and inhibitory prostaglandin receptors on platelet membranes.
    Ashby B
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(4):291-300. PubMed ID: 2432105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of thromboxane antagonists on prostaglandin regulation of platelet adenylate cyclase.
    Ashby B
    Second Messengers Phosphoproteins; 1988-1989; 12(5-6):241-50. PubMed ID: 2483174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor (norepinephrine), P-site (2',5'-dideoxyadenosine), and calcium-mediated inhibition of prostaglandin and forskolin-activated cyclic AMP-generating systems in human platelets.
    Siegl AM; Daly JW
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(3):229-45. PubMed ID: 2991349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
    Williams KA; Murphy W; Haslam RJ
    Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions among prostaglandin receptors.
    Ashby B
    Receptor; 1994; 4(1):31-42. PubMed ID: 8038705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.
    Miller OV; Gorman RR
    J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Iloprost, Cicaprost and prostacyclin effects on cyclic AMP metabolism in intact platelets.
    Ashby B
    Prostaglandins; 1992 Mar; 43(3):255-61. PubMed ID: 1378640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Ns-stimulated human platelet adenylate cyclase by forskolin.
    Watanabe Y; Jakobs KH
    Mol Pharmacol; 1986 Mar; 29(3):258-63. PubMed ID: 3005833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of prostaglandins E1 and E2 in regulation of cyclic-AMP and aggregation in human platelets: evidence for a common prostaglandin receptor.
    McDonald JW; Stuart RK
    J Lab Clin Med; 1974 Jul; 84(1):111-21. PubMed ID: 4365532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the mode of action of 1-oleoyl-2-acetyl-glycerol and phorbol ester in platelet activation.
    Ashby B; Kowalska MA; Wernick E; Rigmaiden M; Daniel JL; Smith JB
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(5):473-83. PubMed ID: 2999204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.
    Watanabe T; Satoh H; Togoh M; Taniguchi S; Hashimoto Y; Kurokawa K
    J Cell Physiol; 1996 Nov; 169(2):401-9. PubMed ID: 8908208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin receptors coupled to adenylyl cyclase in the iris-ciliary body of rabbits, cats and cows.
    Bhattacherjee P; Rhodes L; Paterson CA
    Exp Eye Res; 1993 Mar; 56(3):327-33. PubMed ID: 8386102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prostaglandin D2 and theophylline on rat serosal mast cells: discordance between increased cellular levels of cyclic AMP and activation of cyclic AMP-dependent protein kinase.
    Holgate ST; Winslow CM; Lewis RA; Austen KF
    J Immunol; 1981 Oct; 127(4):1530-3. PubMed ID: 6268708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by ADP of prostaglandin induced accumulation of cyclic AMP in intact human platelets.
    Macfarlane DE; Mills DC
    J Cyclic Nucleotide Res; 1981; 7(1):1-11. PubMed ID: 6265510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.